Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.

On March 31, 2023,
Mizuho
initiated coverage of Amplify YieldShares Oil Hedged MLP Income ETF with
a Buy recommendation.

Analyst Price Forecast Suggests 84.79% Upside

As of March 30, 2023,
the average one-year price target for Amplify YieldShares Oil Hedged MLP Income ETF is $51.20.
The forecasts range from a low of $47.47 to a high of $56.70.
The average price target represents an increase of 84.79% from its latest reported closing price of $27.71.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Amplify YieldShares Oil Hedged MLP Income ETF
is $178MM, an increase of 700.58%.

The projected annual non-GAAP EPS
is -$2.35.

What are Large Shareholders Doing?

AMLX / Amplify YieldShares Oil Hedged MLP Income ETF Shares Held by Institutions

VTSMX – Vanguard Total Stock Market Index Fund Investor Shares
holds 1,506K shares

representing 2.26% ownership of the company.

In it’s prior filing, the firm reported owning 1,225K shares, representing
an increase
of 18.70%.

The firm

increased

its portfolio allocation in AMLX by 49.10% over the last quarter.

NAESX – Vanguard Small-Cap Index Fund Investor Shares
holds 1,279K shares

representing 1.92% ownership of the company.

In it’s prior filing, the firm reported owning 1,041K shares, representing
an increase
of 18.57%.

The firm

increased

its portfolio allocation in AMLX by 49.24% over the last quarter.

IWM – iShares Russell 2000 ETF
holds 1,155K shares

representing 1.73% ownership of the company.

In it’s prior filing, the firm reported owning 763K shares, representing
an increase
of 33.92%.

The firm

increased

its portfolio allocation in AMLX by 79.90% over the last quarter.

KAUAX – Federated Kaufmann Fund Shares
holds 775K shares

representing 1.16% ownership of the company.

No change in the last quarter.

VISGX – Vanguard Small-Cap Growth Index Fund Investor Shares
holds 741K shares

representing 1.11% ownership of the company.

In it’s prior filing, the firm reported owning 602K shares, representing
an increase
of 18.74%.

The firm

increased

its portfolio allocation in AMLX by 54.52% over the last quarter.

What is the Fund Sentiment?

There are 147 funds or institutions reporting positions in Amplify YieldShares Oil Hedged MLP Income ETF.

This is an increase
of
23
owner(s) or 18.55% in the last quarter.

Average portfolio weight of all funds dedicated to AMLX is 0.24%,
an increase
of 34.89%.

Total shares owned by institutions increased
in the last three months by 41.59% to 12,502K shares.

The put/call ratio of AMLX is 0.73, indicating a

bullish
outlook.

Amylyx Pharmaceuticals Background Information
(This description is provided by the company.)

Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Source link

Share:

administrator

Leave a Reply

Your email address will not be published. Required fields are marked *